PU¶PubMed·Journal article·Tinnitus·2w agoEarly Post-Market Surveillance of Bimodal Neuromodulation for TinnitusClinicians fitting or referring patients for Lenire should review the emerging real-world adverse event and efficacy data from MAUDE to counsel patients accurately, though practice-changing conclusions require full review of the published findings.
AudiologyOnline·Regulatory·Tinnitus·4w agoLenire Now Included in U.S. ENT Clinical Practice Guidelines – First New Treatment Added by American Academy of Otolaryngology Since Establishment of the Academy’s Tinnitus GuidelinesAudiologists treating tinnitus patients should be aware that Lenire (bimodal neuromodulation) is now a guideline-recognized option; clinicians with eligible patients may consider discussing or referring for this therapy, though it is not yet a first-line recommendation.+Save
Hearing Tracker·Industry news·Tinnitus·4w agoLenire Now Included in U.S. ENT Clinical Practice GuidelinesAudiologists and ENTs managing tinnitus patients now have guideline-level backing to offer or refer for Lenire bimodal neuromodulation; clinicians should familiarise themselves with AAO-HNSF eligibility criteria and the device's recommended protocol.+Save
Hearing Review·Industry news·Business & finance·6w agoNeuromod Devices Names New Chief Commercial Officer, VP of Channel DevelopmentLeadership investment in commercial expansion signals that Neuromod is pushing harder to bring bimodal neuromodulation tinnitus therapy into mainstream audiology channels globally.+Save
Hearing Health Matters·Industry news·Tinnitus·7w ago· press releaseNeuromod Adds Commercial Leaders to Support Expansion of Lenire Tinnitus TreatmentExpanded commercial leadership at Neuromod could accelerate Lenire's market penetration, giving more audiologists and tinnitus clinics access to bimodal neuromodulation as a treatment option.+Save
Future Ear Radio·Podcast·Tinnitus·2y ago132 - Ross O'Neill, PhD & Hubert Lim, PhD - Lenire: The First FDA-Approved Bimodal Tinnitus TreatmentNeuromod co-founders Ross O'Neill and Hubert Lim discuss the research origins and FDA approval of Lenire, the first FDA-approved bimodal tinnitus treatment device.+Save